JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Hologic Inc

Fechado

SetorSaúde

74.02 0.16

Visão Geral

Variação de preço das ações

24h

Atual

Mín

73.84

Máximo

74.1

Indicadores-chave

By Trading Economics

Rendimento

212M

195M

Vendas

19M

1B

P/E

Médio do Setor

28.98

37.461

EPS

1.08

Margem de lucro

19.037

Funcionários

7,063

EBITDA

341M

334M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+5.42% upside

Dividendos

By Dow Jones

Próximos Ganhos

3 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.3B

16B

Abertura anterior

73.86

Fecho anterior

74.02

Sentimento de Notícias

By Acuity

25%

75%

51 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Hologic Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de out. de 2025, 13:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

27 de mai. de 2025, 18:46 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

21 de out. de 2025, 16:36 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Hologic Seen as Prime Take-Private Candidate -- Market Talk

21 de out. de 2025, 13:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone, TPG to Buy Hologic for Up to $18.3B

21 de out. de 2025, 12:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Plans to File Form 10-K for Fiscal 2025 With the SEC in Late Nov >HOLX

21 de out. de 2025, 12:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Does Not Intend to Provide Fincl Guidance for FY26 in Upcoming 4Q Results Release

21 de out. de 2025, 12:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Merger Agreement Includes a 45-Day 'Go-Shop' Period >HOLX

21 de out. de 2025, 12:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Will Continue to Operate Under the Hologic Name and Brand >HOLX

21 de out. de 2025, 12:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Will Maintain Its Headquarters in Marlborough, Massachusetts >HOLX

21 de out. de 2025, 12:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone's Private Equity Strategy for Individual Investors Is Also Expected to Invest as Part of Transaction

21 de out. de 2025, 12:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone and TPG Secured Committed Financing From Citi, Bank of Amer, Barclays, Royal Bank of Canada and SMBC

21 de out. de 2025, 12:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone and TPG Have Secured Committed Financing for the Transaction >HOLX

21 de out. de 2025, 12:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic: Transaction Includes Significant Minority Investments From Subsidiary of Abu Dhabi Investment Authority and an Affil of GIC >HOLX

21 de out. de 2025, 12:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic: Purchase Price Represents Premium of About 46% to Closing Price on May 23 >HOLX

21 de out. de 2025, 12:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic: Non-tradable CVR Would Be Issued to Holders at Closing and Paid Following Achievement of Certain Global Rev Goals for Breast Health Business in FY26, FY27

21 de out. de 2025, 12:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone and TPG Will Acquire Hologic Shrs for $76/Shr in Cash Plus Non-Tradable CVR to Get Up to $3/Shr for Total of Up to $79/Shr in Cash >HOLX

21 de out. de 2025, 12:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic: Transaction Will Help Strengthen Leadership in Women's Health and Accelerate Growth >HOLX

21 de out. de 2025, 12:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic to Be Acquired by Funds Managed by Blackstone Deal and TPG in Deal With Enterprise Value of Up to $18.3 B >BX HOLX

27 de mai. de 2025, 20:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 de mai. de 2025, 19:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 de mai. de 2025, 18:26 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Comparação entre Pares

Variação de preço

Hologic Inc Previsão

Preço-alvo

By TipRanks

5.42% parte superior

Previsão para 12 meses

Média 78 USD  5.42%

Máximo 94 USD

Mínimo 69 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Hologic Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

13 ratings

3

Comprar

10

Manter

0

Vender

Pontuação Técnica

By Trading Central

52.69 / 58.605Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

51 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
help-icon Live chat